Interplay of Brain-Derived Neurotrophic Factor and Cytokines in Schizophrenia

1. Mizuno K, Carnahan J, Nawa H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev Biol. 1994; 165(1): 243–256.10.1006/dbio.1994.1250Search in Google Scholar

2. Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015; 11(6): 1164-78.10.5114/aoms.2015.56342Search in Google Scholar

3. Zigova T, Pencea V, Wiegand SJ, Luskin MB. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci. 1998; 11: 234–45.10.1006/mcne.1998.0684Search in Google Scholar

4. Carrasco MA, Castro P, Sepulveda FJ, Tapia JC, Gatica K, Davis MI, Aguayo LG. Regulation of glycinergic and GABAergic synaptogenesis by brain-derived neurotrophic factor in developing spinal neurons. Neuroscience. 2007; 145(2): 484–494.10.1016/j.neuroscience.2006.12.019Search in Google Scholar

5. Donovan MJ, Miranda RC, Kraemer R, et al. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am J Pathol. 1995; 147: 309–24.Search in Google Scholar

6. Levada OA, Cherednichenko NV. [Brain-derived neurotrophic factor (BDNF): neurobiology and marker value in neuropsychiatry]. Lik Sprava. 2015; (3-4): 15-25.Search in Google Scholar

7. Hashimoto R, Ohi K, Yamamori H, Yasuda Y, Fujimoto M, Umeda-Yano S, Watanabe Y, Fukunaga M, Takeda M. Imaging Genetics and Psychiatric Disorders. Curr Mol Med. 2015; 15(2): 168–175.10.2174/1566524015666150303104159Search in Google Scholar

8. Kim A, Fagan AM, Goate AM, Benzinger TLS, Morris JC, Head D. Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory. Cogn Affect Behav Neurosci. 2015; 15: 625–643.10.3758/s13415-015-0343-xSearch in Google Scholar

9. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991; 350 (6315): 230–232.10.1038/350230a0Search in Google Scholar

10. Segal RA, Takahashi H, McKay RD. Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron. 1992; 9(6): 1041–1052.10.1016/0896-6273(92)90064-KSearch in Google Scholar

11. Oppenheim RW, Yin QW, Prevette D, Yan Q. Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature. 1992; 360(6406): 755–757.10.1038/360755a01465146Search in Google Scholar

12. Johnson JE, Barde YA, Schwab M, Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci. 1986; 6(10): 3031–3038.10.1523/JNEUROSCI.06-10-03031.1986Search in Google Scholar

13. Elkabes S, DiCicco-Bloom E.M, Black I.B. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 1996; 16, 2508e2521.Search in Google Scholar

14. Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW. Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor. The Journal of Neuroscience, March 1, 1999; 19(5): 1708–1716.10.1523/JNEUROSCI.19-05-01708.1999Search in Google Scholar

15. Schulte-Herbruggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. Neuroimmunol 2005; 160(1-2):204-9.10.1016/j.jneuroim.2004.10.02615710474Search in Google Scholar

16. Rosenthal A, Goeddel DV, Nguyen T, Martin E, Burton LE, Shih A, Laramee GR, Wurm F, Mason A, Nikolics K, Winslon JW: Primary structure and biological activity of human brain-derived neurotrophic factor. Endocrinology 1991; 129: 1289-1294.10.1210/endo-129-3-12891874171Search in Google Scholar

17. Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsuma T: Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem Res 1996; 21: 929-938.10.1007/BF025323438895847Search in Google Scholar

18. Katoh-Semba R, Takeuchi IK, Semba R, Kato K: Distribution of brain-derived neurotrophic factor in rats and its changes with development in the brain. J Neurochem 1997; 69: 34-42.Search in Google Scholar

19. Scarisbrick IA, Jones EG, Isackson PJ: Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. J Neurosci 1993; 13: 875-893.10.1523/JNEUROSCI.13-03-00875.1993Search in Google Scholar

20. Maroder M, Bellavia D, Meco D, Napolitano M, Stigliano A, Alesse E, Vacca A, Giannini G, Frati L, Gulino A, Screpanti I: Expression of trKB neurotrophin receptor during T cell development: role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol 1996; 157: 2864-2872.Search in Google Scholar

21. Matsuda S, Fujita T, Kajiya M, Takeda K, Shiba H, Kawaguchi H, Kurihara H. Brain-derived neurotrophic factor induces migration of endothelial cells through a TrkB-ERK-integrin αVβ3-FAK cascade. J Cell Physiol. 2012; 227(5): 2123-9.10.1002/jcp.2294221769870Search in Google Scholar

22. Dormady SP, Bashayan O, Dougherty R, Zhang XM, Basch RS. Immortalized multipotentialmesenchymal cells and the hematopoietic microenvironment. J Hematother Stem Cell Res. 2001; 10(1): 125-40.10.1089/15258160175009837211276366Search in Google Scholar

23. Dwivedi Y. Involvement of Brain-Derived Neurotrophic Factor in Late-Life Depression. Am J Geriatr Psychiatry. 2013; 21(5): 433–449.10.1016/j.jagp.2012.10.026376738123570887Search in Google Scholar

24. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 2007; 85(3): 525-35.10.1002/jnr.21139187850917149751Search in Google Scholar

25. Akyol ES, Albayrak Y, Beyazyuz M, Aksoy N, Kuloglu M, Hashimoto K. Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome. Neuropsychiatr Dis Treat. 2015; 11: 865-72.Search in Google Scholar

26. Diniz B.S, Teixeira A.L, Machado-Vieira R, Talib L.L, Radanovic M, Gattaz W.F, Forlenza O.V. Reduced cerebrospinal fluid levels of brain-derived neurotrophic factor is associated with cognitive impairment in late-life major depression. Journals of Gerontology, Series B: Psychological Sciences and Social Sciences, 2014; 69(6): 845–851.10.1093/geronb/gbu096421755425149921Search in Google Scholar

27. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, Mahadik SP. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsychopharmacol. 2010; 13(4): 535-9.10.1017/S1461145709991015Search in Google Scholar

28. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998; 37(12): 1553-61.10.1016/S0028-3908(98)00141-5Search in Google Scholar

29. Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014; 8: 430.10.3389/fncel.2014.00430Search in Google Scholar

30. Eyre H, Baune BT. Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology. 2012; 37(9): 1397-1416.10.1016/j.psyneuen.2012.03.019Search in Google Scholar

31. Zha XM, Bishop JF, Hansen MR, Victoria L, Abbas PJ, Mouradian MM, Green SH. BDNF synthesis in spiral ganglion neurons is constitutive and CREB-dependent. Hear Res. 2001; 156 (1-2): 53-68.10.1016/S0378-5955(01)00267-2Search in Google Scholar

32. Murphy PG, Borthwick LA, Altares M, Gauldie J, Kaplan D, Richardson PM. Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons. Eur J Neurosci 2000; 12(6): 1891-9.10.1046/j.1460-9568.2000.00074.xSearch in Google Scholar

33. Lapchak PA, Araujo DM, Hefti F. Systemic interleukin-1 betadecreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience. 1993; 53(2): 297–301.10.1016/0306-4522(93)90196-MSearch in Google Scholar

34. Tong L, Prieto GA, Kramár EA, Smith ED, Cribbs DH, Lynch G, Cotman CW. Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase. J Neurosci 2012; 32: 17714-24.10.1523/JNEUROSCI.1253-12.2012368758723223292Search in Google Scholar

35. Böni-Schnetzler M, Donath MY. Increased IL-1β activation, the culprit not only for defective insulin secretion but also for insulin resistance? Cell Res. 2011; 21(7): 995-7.10.1038/cr.2011.85319349921606953Search in Google Scholar

36. Tong L, Balazs R, Soiampornkul R, Thangnipon W, Cotman CW. Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction. Neurobiol Aging 2008; 29(9): 1380-93.10.1016/j.neurobiolaging.2007.02.027405288917467122Search in Google Scholar

37. Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A. Production and functions of IL-17 in microglia. J Neuroimmunol. 2008; 194(1-2): 54-61.10.1016/j.jneuroim.2007.11.006Search in Google Scholar

38. Lin G, Zhang H, Sun F, Lu Z, Reed-Maldonado A, Lee YC, Wang G, Banie L, Lue TF. Brain-derived neurotrophic factor promotes nerve regeneration by activating the JAK/STAT pathway in Schwann cells. Transl Androl Urol. 2016; 5(2): 167-75.10.21037/tau.2016.02.03Search in Google Scholar

39. Liongue C, O’Sullivan LA, Trengove MC, Ward AC. Evolution of JAK-STAT pathway components: mechanisms and role in immune system development. PLoS One. 2012; 7(3): e32777.10.1371/journal.pone.0032777Search in Google Scholar

40. Dugan AM, Parrott JM, Redus L, Hensler JG, O’Connor JC. Low-Level Stress Induces Production of Neuroprotective Factors in Wild-Type but Not BDNF+/− Mice: Interleukin-10 and Kynurenic Acid. Int J Neuropsychopharmacol 2015; 19(3): pyv089.10.1093/ijnp/pyv089Search in Google Scholar

41. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer’s disease. Neuron. 1991; 7(5): 695-702.10.1016/0896-6273(91)90273-3Search in Google Scholar

42. Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol. 2009; 5(6): 311-22.10.1038/nrneurol.2009.54Search in Google Scholar

43. Hori H, Yoshimura R, Katsuki A, Atake K, Igata R, Konishi Y, Nakamura J. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy. World J Biol Psychiatry. 2016; 13: 1-30.Search in Google Scholar

44. Castrén E, Kojima M. Brain-derived neurotrophic factor in mood disorders and antidepressant treatments. Neurobiol Dis. 2016; pii: S0969-9961(16)30169-3.Search in Google Scholar

45. Mansur RB, Santos CM, Rizzo LB, Asevedo E, Cunha GR, Noto MN, Pedrini M, Zeni-Graiff M, Cordeiro Q, Vinberg M, Kapczinski F, McIntyre RS, Brietzke E. Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course. Bipolar Disord. 2016; 18(4): 373-8.10.1111/bdi.12399Search in Google Scholar

46. Zsuga J, Tajti G, Papp C, Juhasz B, Gesztelyi R. FNDC5/irisin, a molecular target for boosting reward-related learning and motivation. Med Hypotheses. 2016; 90: 23-8.10.1016/j.mehy.2016.02.020Search in Google Scholar

47. Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience. 2003; 119(3): 767-75.10.1016/S0306-4522(03)00099-XSearch in Google Scholar

48. Fumagalli F, Bedogni F, et al. Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci. 2004; 20(5): 1348–1354.10.1111/j.1460-9568.2004.03592.x15341606Search in Google Scholar

49. Chen SL, Lee SY, Chang YH, Chen SH, Chu CH, Tzeng NS, Lee IH, Chen PS, Yeh TL, Huang SY, Yang YK, Lu RB, Hong JS. J. Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan. Neuroimmune Pharmacol. 2012; 7(3): 656-64.10.1007/s11481-012-9382-z361109722730040Search in Google Scholar

50. Strube W, Nitsche MA, Wobrock T, Bunse T, Rein B, Herrmann M, Schmitt A, Nieratschker V, Witt SH, Rietschel M, Falkai P, Hasan A. BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study. International Journal of Neuropsychopharmacology. 2015: 18(4): pyu040.10.1093/ijnp/pyu040436022925612896Search in Google Scholar

51. Leonard BE, Schwarz M, Myint AM. The metabolic syndrome in schizophrenia: is inflammation a contributing cause? J Psychopharmacol. 2012; 26(5 Suppl): 33-41.10.1177/026988111143162222472311Search in Google Scholar

52. Monji A, Kato T.A, Mizoguchi Y, Horikawa H, Seki Y, Kasai M, Yamauchi Y, Yamada S, Kanba S. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2013; 42: 115–121.Search in Google Scholar

53. Kato TA, Monji A, Mizoguchi Y, Hashioka S, Horikawa H, Seki Y, Kasai M, Utsumi H, Kanba S. Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a ‘fire extinguisher’ in the brain of schizophrenia? Mini Rev Med Chem. 2011; 11(7): 565-74.10.2174/13895571179590694121699487Search in Google Scholar

54. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Bankovic D, Arsenijevic N, Lukic ML. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res. 2012; 46 (11): 1421-6.10.1016/j.jpsychires.2012.08.01622974591Search in Google Scholar

55. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML. Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response. Schizophr Res. 2013; 147 (1): 103-9.10.1016/j.schres.2013.03.02723602340Search in Google Scholar

56. Stefanović V, Mihajlović G, Nenadović M, Dejanović SD, Borovcanin M, Trajković G. Vojnosanit Pregl. The effect of antipsychotic drugs on nonspecific inflammation markers in the first episode of schizophrenia. 2015; 72(12):1085-92.Search in Google Scholar

57. Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia. Psychoneuroendocrinology. 2015; 56: 143-7.10.1016/j.psyneuen.2015.03.00325827958Search in Google Scholar

58. Borovcanin M, Jovanovic I, Djukic Dejanovic S, Radosavljevic G, Arsenijevic N, Lukic ML. Possible role of TGF-β pathways in schizophrenia. Ser J Exp Clin Res 2016; 17 (1): 3-8.10.1515/sjecr-2015-0038Search in Google Scholar

59. Noto CS, Gadelha A, Belangero SI, Smith MAC, W. de Aguiar B, Panizzuti B, Mari JJ, Gama CS, Bressan RA, Brietzke E. Association of biomarkers and depressive symptoms in schizophrenia. Neuroscience Letters. 2011; 505(3): 282–5.10.1016/j.neulet.2011.10.04222044873Search in Google Scholar

60. Zhang XY, Tan YL, Chen DC, Tan SP, Yang FD, Wu HE, Zunta-Soares GB, Huang XF, Kosten TR, Soares JC. Interaction of BDNF with cytokines in chronic schizophrenia. Brain Behav Immun. 2016; 51: 169-75.10.1016/j.bbi.2015.09.01426407757Search in Google Scholar

61. Mahendran R, Mahendran R, Chan YH. Interleukin-2 levels in chronic schizophrenia patients. Ann Acad Med Singapore. 2004; 33(3): 320-3.Search in Google Scholar

62. Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, Perrin M, Gorman JM, Susser ES. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004; 161(5): 889-95.10.1176/appi.ajp.161.5.88915121655Search in Google Scholar

63. Pirildar S, Gonul AS, Taneli F, Akdeniz F. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28(4): 709-13.10.1016/j.pnpbp.2004.05.00815276697Search in Google Scholar

64. Zhang XY, Liang J, Chen da C, Xiang, Hong Xiu M, Yang FD, Kosten A. T, Kosten R. T. Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl). 2012; 222: 277-84.10.1007/s00213-012-2643-y22274000Search in Google Scholar

65. Green M.J, Matheson S.L, Shepherd A, Weickert C.S, Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatry. 2011; 16 (9): 960–972.Search in Google Scholar

66. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res. 2003; 71(1): 127-31.10.1002/jnr.1044012478621Search in Google Scholar

67. Xiu MH, Hui L, Dang YF, Hou TD, Zhang CX, Zheng YL, Chen da C, Kosten TR, Zhang XY. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(8): 1508-12.10.1016/j.pnpbp.2009.08.01119720106Search in Google Scholar

68. Yoshimura R, Hori H, Sugita A, Ueda N, Kakihara S, Umene W, Nakano Y, Shinkai K, Mitoma M, Ohta M, Shinkai T, Nakamura J. Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(5): 1072-7.10.1016/j.pnpbp.2007.03.01017459549Search in Google Scholar

69. Holt RI, Bushe C and Citrome L. Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol. 2005; 19 (Suppl.6): 56–65.10.1177/026988110505837916280338Search in Google Scholar

70. Jin H, Meyer JM, Mudaliar S and Jeste DV. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res. 2008; 100: 70–85.10.1016/j.schres.2007.11.026269976918206351Search in Google Scholar

71. Zhang Y, Chen M, Wu Z, Chen J, Yu S, Fang Y, Zhang C. Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results. PLoS One. 2013; 8(8): e72652.10.1371/journal.pone.0072652374272123967328Search in Google Scholar

72. Gajewska E, Sobieska M, Łojko D, Wieczorowska-Tobis K, Suwalska A. Obesity itself does not influence BDNF serum levels in adults. Eur Rev Med Pharmacol Sci. 2014; 18(21): 3246-50.Search in Google Scholar

73. Chaldakov GN, Fiore M, Hristova MG, Aloe L. Metabotrophic potential of neurotrophins: implication in obesity and related diseases? Med Sci Monit. 2003; 9(10): HY19-21.Search in Google Scholar

74. Pedersen MS, Benros ME, Agerbo E, Borglum AD, Mortensen PB. Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res. 2012; 138(1): 58-62.10.1016/j.schres.2012.02.01922391212Search in Google Scholar

75. Prakash YS, Martin RJ. Brain-derived neurotrophic factor in the airways. Pharmacol Ther. 2014; 143(1): 74-86.10.1016/j.pharmthera.2014.02.006399025124560686Search in Google Scholar

76. Watanabe T, Fajt ML, Trudeau JB, Voraphani N, Hu H, Zhou X, Holguin F, Wenzel SE. Brain-Derived Neurotrophic Factor Expression in Asthma. Association with Severity and Type 2 Inflammatory Processes. Am J Respir Cell Mol Biol. 2015; 53(6): 844-52.10.1165/rcmb.2015-0015OC474294225945802Search in Google Scholar

77. Pae CU, Yoon CH, Kim TS, Kim JJ, Park SH, Lee CU, Lee SJ, Lee C, Paik IH. Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines. Int Immunopharmacol. 2006; 6(4): 666-71.10.1016/j.intimp.2005.10.00416504930Search in Google Scholar

78. Lu J, Kang J, Zhang C, Zhang X. The role of IL-33/ST2L signals in the immune cells. Immunol Lett. 2015; 164(1): 11-7.10.1016/j.imlet.2015.01.00825662624Search in Google Scholar

79. Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 2015; 519 (7542): 242-6.10.1038/nature14115444723525533952Search in Google Scholar

80. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST, McKenzie AN, Fallon PG, Ogg GS. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013; 210(13): 2939-50.10.1084/jem.20130351386547024323357Search in Google Scholar

81. Raap U, Goltz C, Deneka N, Bruder M, Renz H, Kapp A and Wedi B. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compaired with that seen in nonatopic subjects. J Allergy Clin Immunol. 2005; 115(6):1268-75.10.1016/j.jaci.2005.02.00715940146Search in Google Scholar

82. Zipris P, Melamed Y, Weizman A, Bleich A. Clozapine-Induced Eosinophilia and Switch to Quetiapine in a Patient with Chronic Schizophrenia with Suicidal Tendencies. Isr J Psychiatry Relat Sci. 2007; 44(1): 54-6.Search in Google Scholar

83. Jin P, Andiappan AK, Quek JM, Lee B, Au B, Sio YY, Irwanto A, Schurmann C, Grabe HJ, Suri BK, Matta SA, Westra HJ, Franke L, Esko T, Sun L, Zhang X, Liu H, Zhang F, Larbi A, Xu X, Poidinger M, Liu J, Chew FT, Rotzschke O, Shi L, Wang de Y. A functional brain-derived neurotrophic factor (BDNF) gene variant increases the risk of moderate-to-severe allergic rhinitis. J Allergy Clin Immunol. 2015; 135(6): 1486-93.10.1016/j.jaci.2014.12.187025649076Search in Google Scholar